Details of the Drug

General Information of Drug (ID: DMRC0EQ)

Drug Name
Bertilimumab
Synonyms CAT-213; ICo-008
Indication
Disease Entry ICD 11 Status REF
Bullous pemphigoid EB41.0 Phase 2 [1]
Ocular allergy 4A81 Phase 2 [2]
Psoriasis vulgaris EA90 Phase 2 [3]
Ulcerative colitis DD71 Phase 2 [3]
Drug Type
Monoclonal antibody
Structure 3D Structure is Not Available
3D MOL 2D MOL
Cross-matching ID
TTD ID
D0V9LY
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Small-inducible cytokine A11 (CCL11) TTCF05Y CCL11_HUMAN Modulator [4]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.